U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
3009130091Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)AvailableNo Results AvailableIdiopathic Pulmonary FibrosisDrug: nintedanibhttps://ClinicalTrials.gov/show/NCT02171156
3009230092A Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ASP2409 Following a Single Intravenous Dose in Patients With Rheumatoid Arthritis on MethotrexateCompletedNo Results AvailableRheumatoid Arthritis|Pharmacokinetics of ASP2409Drug: ASP2409|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02171143
3009330093Clinical Usability of Intranasal Glucagon in Treatment of HypoglycemiaActive, not recruitingNo Results AvailableHypoglycemia|Diabetes Mellitus|Drug-Specific AntibodiesDrug: 3 mg glucagon powderhttps://ClinicalTrials.gov/show/NCT02171130
3009430094Safety and Efficacy Study of Microtransplantation to Treat Elderly Acute Myeloid LeukemiaRecruitingNo Results AvailableAcute Myeloid LeukemiaProcedure: microtransplantation|Biological: HLA-mismatched donor peripheral stem cell infusionhttps://ClinicalTrials.gov/show/NCT02171117
3009530095MT2013-31: Allo HCT for Metabolic Disorders and Severe OsteopetrosisRecruitingNo Results AvailableMucopolysaccharidosis I|Mucopolysaccharidosis II|Mucopolysaccharidosis VI|Mucopolysaccharidosis VII|Hurler Syndrome|Hunter Syndrome|Maroteaux Lamy Syndrome|Sly Syndrome|Glycoprotein Metabolic Disorders|Alpha Mannosidosis|Fucosidosis|AspartylglucosaminuriaProcedure: blood stem cell transplant|Drug: Rabbit Anti-Thymocyte Globulin (ATG)|Drug: Fludarabine|Drug: Busulfan|Drug: Cyclophosphamide|Drug: Cyclosporine A (CSA)|Drug: Methylprednisolone|Drug: Mycophenolate Mofetil (MMF)|Drug: Granulocyte-Colony Stimulating Factor (G-CSF)|Drug: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)|Drug: N-acetylcysteine|Drug: Celecoxib|Drug: Vitamin E|Drug: Alpha Lipoic Acidhttps://ClinicalTrials.gov/show/NCT02171104
3009630096Intubated ICU PatientsRecruitingNo Results AvailablePatients Requiring Endotracheal Intubationhttps://ClinicalTrials.gov/show/NCT02171091
3009730097Post-Treatment Surveillance in Breast Cancer: Bringing CER to the AllianceActive, not recruitingNo Results AvailableBreast Neoplasmshttps://ClinicalTrials.gov/show/NCT02171078
3009830098PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomized Trial.RecruitingNo Results AvailableAcute Coronary Syndrome (ACS)Device: sham|Device: ABSORB BVShttps://ClinicalTrials.gov/show/NCT02171065
3009930099Relative Bioavailability of Dabigatran and Digoxin in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: Dabigatran etexilate|Drug: Digoxinhttps://ClinicalTrials.gov/show/NCT02171052
3010030100Relative Bioavailability of Dabigatran and Atorvastatin in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: Dabigatran|Drug: Atorvastatinhttps://ClinicalTrials.gov/show/NCT02171039
3010130101Bioavailability of Dabigatran and Amiodarone After Multiple Oral Administrations of Dabigatran Etexilate With or Without Amiodarone as Single Dose in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: Dabigatran etexilate|Drug: Amiodaronehttps://ClinicalTrials.gov/show/NCT02171026
3010230102Bioequivalence of Two Different Drug Product Batches of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: Dabigatran polymorph I (≈ 83%) and polymorph II (≈17%)|Drug: Dabigatran polymorph Ihttps://ClinicalTrials.gov/show/NCT02171013
3010330103Safety, Pharmacokinetics and Pharmacodynamics After Multiple Oral Doses of BIBR 1048 MS Capsule in Healthy Japanese Male SubjectsCompletedNo Results AvailableHealthyDrug: BIBR 1048 MShttps://ClinicalTrials.gov/show/NCT02171000
3010430104Assessment of Electrophysiological Effects of Dabigatran Etexilate as Single Dose on the QT Interval in Healthy Female and Male Subjects.CompletedNo Results AvailableHealthyDrug: Dabigatran etexilate low|Drug: Dabigatran etexilate high|Drug: Moxifloxacin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02170987
3010530105Bioavailability of BIBR 953 ZW After BIBR 1048 (Oral Pro-drug of BIBR 953 ZW) Administered as Hydroxypropyl Methylcellulose (HPMC) Polymorph II Capsule Relative to HPMC Polymorph I Capsule in Healthy Subjects.CompletedNo Results AvailableHealthyDrug: BIBR 1048 MS polymorph II|Drug: BIBR 1048 MS polymorph Ihttps://ClinicalTrials.gov/show/NCT02170974
3010630106Study of Polymorphisms of RAAS and MMPs in Acute Heart FailureRecruitingNo Results AvailableAcute Heart Failurehttps://ClinicalTrials.gov/show/NCT02170961
3010730107The Effectiveness of the Addition of Dexmedetomidine to Analgesia for Ankle Surgery.RecruitingNo Results AvailableAnesthesiaDrug: Dexmedetomidinehttps://ClinicalTrials.gov/show/NCT02170948
3010830108Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement SurgeryCompletedNo Results AvailableVenous ThromboembolismDrug: BIBR 1048 capsulehttps://ClinicalTrials.gov/show/NCT02170935
3010930109Bioavailability of BIBR 1048 MS Tablets in Healthy Subjects With or Without FoodCompletedNo Results AvailableHealthyDrug: BIBR 1048 MS tablet|Drug: BIBR 1048 MS solutionhttps://ClinicalTrials.gov/show/NCT02170922
3011030110Safety, Pharmacokinetics and Pharmacodynamics of BIBR 1048 MS Capsule in Healthy Male Subjects of Japanese and Caucasian OriginCompletedNo Results AvailableHealthyDrug: BIBR 1048 MS low dose|Drug: BIBR 1048 MS medium dose|Drug: BIBR 1048 MS high dosehttps://ClinicalTrials.gov/show/NCT02170909
3011130111Bioavailability of BIBR 963 ZW After 50 mg of BIBR 1048 MS With and Without of Pantoprazole in Healthy SubjectsCompletedNo Results AvailableHealthyDrug: BIBR 1048 MS Capsule A|Drug: BIBR 1048 MS Capsule B|Drug: BIBR 1048 MS Capsule C|Drug: BIBR 1048 MS Capsule D|Drug: BIBR 1048 MS tartaric acid solution|Drug: Pantoprazolehttps://ClinicalTrials.gov/show/NCT02170896
3011230112EmPhAsIS: Empowering Pharmacists in Asthma Management Through Interactive SMSNot yet recruitingNo Results AvailableAsthmaOther: Interactive SMS|Other: Usual carehttps://ClinicalTrials.gov/show/NCT02170883
3011330113Gastrointestinal Sensorimotor Dysfunctions in Diabetes MellitusRecruitingNo Results AvailableDyspepsia|Diabetes Mellitus With Gastrointestinal SymptomsDrug: Exendin 9-39|Drug: Microlipid|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02170870
3011430114Effect of Hyaluronic Acid in the Treatment of Periodontal PocketsRecruitingNo Results AvailableChronic Periodontitis With Infra-bony DefectsDrug: Hyaluronic Acidhttps://ClinicalTrials.gov/show/NCT02170857
3011530115Safety, Pharmacokinetics and Pharmacodynamics After Single Rising Oral Doses of BIBR 1048 MS as Capsules in Healthy Subjects of Japanese and Caucasian OriginCompletedNo Results AvailableHealthyDrug: BIBR 1048 MS|Drug: Placebo of BIBR 1048 MShttps://ClinicalTrials.gov/show/NCT02170844
3011630116Multiple Oral Doses of BIBR 1048 MS Solution in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: BIBR 1048 MS low|Drug: BIBR 1048 MS medium 1|Drug: BIBR 1048 MS medium 2|Drug: BIBR 1048 MS high|Drug: BIBR 1048 MS placebohttps://ClinicalTrials.gov/show/NCT02170831
3011730117Improving Faculty's Ability to Speak Up to Others in the Operating RoomCompletedNo Results AvailableFaculty, MedicalOther: Educational Workshop on Speaking-Up|Other: Unrelated Education (CPR)https://ClinicalTrials.gov/show/NCT02170818
3011830118Bioavailability of BIBR 1048 MS Single Doses With or Without Pantoprazole in Healthy SubjectsCompletedNo Results AvailableHealthyDrug: BIBR 1048 MS capsule formulation A|Drug: BIBR 1048 MS capsule formulation B|Drug: BIBR 1048 MS powder plus solution|Drug: Pantoprazolehttps://ClinicalTrials.gov/show/NCT02170805
3011930119Bioavailability of BIBR 953 ZW After Dose of BIBR 1048 MSCompletedNo Results AvailableHealthyDrug: BIBR 1048 MS|Drug: Ranitidinehttps://ClinicalTrials.gov/show/NCT02170792
3012030120Developing and Testing a Comprehensive MS Spasticity Management ProgramNot yet recruitingNo Results AvailableMultiple Sclerosis|SpasticityBehavioral: Spasticity: Take Control|Other: Usual carehttps://ClinicalTrials.gov/show/NCT02170779

* Görseller ve İçerik tekif hakkına sahip olabilir